title: Dose-finding, double-blind, clinical trial of recombinant human erythropoietin (Chugai) in Japanese patients with end-stage renal disease. Research Group for Clinical Assessment of rhEPO.
authors.affiliation: Department of Internal Medicine, Shinrakuen Hospital, Niigata.
authors.forename: M
authors.initials: M
authors.lastname: Suzuki
authors.forename: Y
authors.initials: Y
authors.lastname: Hirasawa
authors.forename: K
authors.initials: K
authors.lastname: Hirashima
authors.forename: M
authors.initials: M
authors.lastname: Arakawa
authors.forename: M
authors.initials: M
authors.lastname: Odaka
authors.forename: Y
authors.initials: Y
authors.lastname: Ogura
authors.forename: Y
authors.initials: Y
authors.lastname: Yoshikawa
authors.forename: T
authors.initials: T
authors.lastname: Sanaka
authors.forename: A
authors.initials: A
authors.lastname: Shinoda
authors.forename: H
authors.initials: H
authors.lastname: Morii
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000740:Anemia / Q000097:blood / Q000150:complications / Q000188:drug therapy; D001803:Blood Transfusion; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004921:Erythropoietin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000139:chemically induced; D007564:Japan; D007676:Kidney Failure, Chronic / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011897:Random Allocation
chemical_list: D004921:Erythropoietin